کد مقاله | کد نشریه | سال انتشار | مقاله انگلیسی | نسخه تمام متن |
---|---|---|---|---|
2100561 | 1083007 | 2007 | 17 صفحه PDF | دانلود رایگان |
![عکس صفحه اول مقاله: Risk assessment in haematopoietic stem cell transplantation: Minor histocompatibility antigens Risk assessment in haematopoietic stem cell transplantation: Minor histocompatibility antigens](/preview/png/2100561.png)
Minor histocompatibility (H) antigens are key molecules in graft-versus-host disease (GvHD) and the graft-versus-tumour effect after allogeneic stem-cell transplantation (SCT). Today, molecular typing methods allow an easy assessment of differences in minor H antigens between patient and donors, so that the GvHD risk in individual patients can be estimated. However, the large number of minor H antigens prevents matching for them to avoid GvHD. Interestingly, mismatching for minor H antigens might improve the outcome of allogeneic SCT. Some minor H antigens are expressed mainly by malignant cells and can therefore serve as excellent targets for cancer immunotherapy. Thus, mismatching for tumour-expressed minor H antigens allows boosting of the curative effect of allogeneic SCT. Current research is elucidating the impact of e.g. donor immunization, immunodominance, or functional expression of minor H antigens on the extent of the GvH response.
Journal: Best Practice & Research Clinical Haematology - Volume 20, Issue 2, June 2007, Pages 171–187